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Abstract
Nitric oxide (NO) is known to have a very short half‐life, and it is oxidized to nitrate 
(NO
3
−) and nitrite (NO
2
−). The activity and/or expression of nitric oxide synthases 
(NOSs) can change in response to toxins or therapeutic medications. For example, in 
recent studies in our laboratory and others, it has been reported that the amount of NO 
was increased in the serum of N‐nitroso compounds‐treated animals. N‐nitroso com‐
pounds, which are found in different types of foodstuffs, including meat, salted fish, 
alcoholic beverages, agricultural drugs, insecticides, cigarettes, and several vegetables, 
are known to have carcinogenic effects. In addition, it is experimentally used to induce 
liver carcinoma to study the mechanisms of liver cytotoxic injury. Uncontrolled, pro‐
longed, and/or massive production of NO by inducible NOS may cause liver damage, 
inflammation, and even tumor development during N‐nitroso compound toxicity. In 
this chapter, we explain the roles of NOS and NO in various toxicity conditions, such 
as toxicity in environment pollutant or food additive, and present the evaluation of the 
toxicity and the importance of NOSs in human health.
Keywords: nitric oxide synthase, nitrate, nitrite, nitric oxide, N‐nitroso compounds, 
toxicity
1. Introduction
Nitric oxide (NO) is synthesized by nitric oxide synthase (NOS) (EC: 1.14.13.39) through 
oxidation of L‐arginine to L‐citrulline [1–5]. NO is a biologically significant molecule for 
many species from bacteria to mammals. Mechanisms for NO synthesis in an organism 
are extremely limited. Nitric oxide synthase enzyme is the only source of endogenous NO, 
except NO formed by metabolism of the nitro compounds entering the organism [6]. Three 
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 different types of NOS isoforms have been isolated from different tissues, such as vascular 
endothelium, brain, macrophage, and urinary system, of mammals, including (a) neuronal 
NOS (nNOS), (b) inducible NOS (iNOS), and (c) endothelial NOS (eNOS) [5, 7]. Neuronal 
NOS (nNOS, NOS1) is a Ca+2‐dependent, ~160 kDa enzyme that is found in the central and 
peripheral nervous system cells and striated muscle [4, 8]. Inducible NOS (iNOS, NOS2) is a 
calcium‐insensitive, ~130 kDa enzyme that was first isolated from activated macrophages and 
that can be activated by some cytokines (IL‐1, TNF, IF‐γ) or bacterial endotoxins [4, 9, 10]. 
Endothelial NOS (eNOS, NOS3) is a Ca+2/calmodulin‐dependent, ~135 kDa enzyme that is 
localized in vascular endothelial cells, hippocampal neural cells, pulmonary and renal epithe‐
lial cells, and cardiac myocytes [4, 9, 11].
Level of NO can be determined indirectly by measuring the concentration of nitrate (NO
3
−) 
and nitrite (NO
2
−) using an acidic Griess reaction. In recent studies in our laboratory and oth‐
ers, it has been reported that the amount of NO can change in response to various toxicity 
conditions [12–18] which are closely associated with animal and human disease conditions. 
In this chapter, we mention NO
3
− and NO
2
−, the molecules which are naturally found in foods 
as NO sources, agricultural activities such as the use of artificial fertilizers, polluted water, 
curing process to give a natural smell and taste to meat. The conversion of NO
3
− and NO
2
− 
into NO in the gastrointestinal tract, the effect of NOS, and possible mechanisms for how 
it is converted back into NO
3
− and NO
2
− in the bloodstream will also be covered. Studies on 
N‐nitrosamines, which are formed by reaction of NO
3
− and NO
2
− with amines, and which can 
be seen in cured meats, cigarette smoke, and rubber industry, reveal the carcinogenic effects 
of these molecules (Figure 1).
Figure 1. Formation of N‐nitroso compounds from NO
3
−, NO
2
−, NO, and their effects on human health.
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2. NO
3
− and NO
2
− as environment pollutants and food additives
Nitrogen is the basic element for essential micromolecules, such as amino acids, proteins, 
and nucleic acids. Nitrogen is the most abundant gas in the atmosphere; however, it has 
to be fixated before it is taken by plants and animals. Fixation is an important part of the 
nitrogen cycle. In this cycle, N
2
 is converted into ammonium and various nitrogen oxides. 
These higher nitrogen oxides are eventually gradually reduced. The nitrogen is then freed 
into the atmosphere and the cycle is completed. Bacteria play an important role in the cycle 
as they can catalyze each step, including the interconversion of different nitrogen oxides. 
NO
3
−, NO
2
−, and NO are all necessary intermediate products in the denitrification process 
and are catalyzed by NO
3
−, NO
2
−, and NO reductases, respectively [19]. Bacteria use these 
molecules as terminal electron acceptors in the absence of oxygen. The production and 
metabolism of nitrogen oxides also occur in mammals. NO
3
− is easily converted into NO
2
− in 
mammals by the activity of enzymes in both bacteria and mammals. The NO
2
− then later can 
react with different molecules, such as amines, amides, and to form N‐nitroso compounds 
which can be carcinogenic [20]. Potentially carcinogenic or inert oxidizing molecules, such 
as NO
3
− and NO
2
−, occur as a result of endogenous NO metabolism during the food chain 
(Figure 1) [21].
Although nitrogen is found naturally in surface waters, its amount increases in many parts of 
the world. The reason for this is the pollution caused by commonly used inorganic fertilizers, 
soil drainage, or contamination of water resources by sewage [22]. The main causes of water 
pollution are pollution from industrial and agricultural activities. Chemical fertilizers used 
in agricultural production have an important role. NO
3
− is applied in increasing amounts in 
the fertilizers for agricultural production, and they accumulate in the soil. This accumulated 
NO
3
−, in varying amounts depending on the conditions, moves toward the deeper parts of the 
ground especially with rainwater, and some of it reaches underground and some to surface 
waters. High NO
3
− concentrations in water resources pose a potential risk to human health, 
because sunlight and some bacteria can easily convert NO
3
− into NO
2
− [23]. NO
3
− and NO
2
− can 
also occur spontaneously in vegetables and fruits consumed by humans and especially in 
animal feed [24]. Vegetables and fruits usually receive NO
3
− and NO
2
− from the soil [25]. As a 
result of nitrogenous fertilizers being used in excess to increase appearance and yield in the 
plants, plants store NO
3
− in excess of their need. When the amount of received NO
3
− is high, 
the reduction to ammonia is limited and NO
2
− accumulates as an intermediate metabolism 
product [26, 27].
Excess NO
3
− and NO
2
− can also be utilized to cure meats. In order to improve the taste, pro‐
tection, appearance, and quality of the meat, NO
3
− and NO
2
− are used for curing purposes. 
NO
2
− can also be used as a preservative against the proliferation of microorganisms, especially 
Clostridium botulinum. It also inhibits lipid peroxidation and prevents putrefaction [28].
Dietary NO
3
− and NO
2
−, which are taken by the organisms, could cause various physiological 
and pathological outcomes.
Nitric Oxide Synthase and Nitric Oxide Involvement in Different Toxicities
http://dx.doi.org/10.5772/intechopen.68494
199
3. Conversion of NO
3
− and NO
2
− into NO in the gastrointestinal system: 
possible role of NOSs
In an organism, NO
2
− is converted into NO in three ways:
(a) It is enzymatically (via NOSs) reduced to NO in the circulation and tissues.
(b) It is non‐enzymatically reduced to NO in acidic stomach environment, capillary beds, and 
at low pH and hypoxic conditions that occur during intense exercise.
(c) NO can be produced by acidification of NO
2
− in the oral cavity.
In this section, the conversion of NO
3
− and NO
2
−, taken from foods in the gastrointestinal tract, 
into NO will be mentioned. At the end of this pathway, NO
3
− and NO
2
− are synthesized again 
from NO. This synthesis in the tissues is catalyzed by NOSs. With the identification of the 
NO
3
−‐NO
2
−‐NO pathway, the importance of the diet, rather than the biological significance of 
systemic NO
3
− and NO
2
−, in the physiological regulation of NO has arisen. NO
3
−, rich in green 
leafy vegetables such as beetroot, is reduced to NO
2
− by bacterial NO
3
− reductase in the com‐
mensal anaerobic microflora in the oral cavity by saliva secretion and is reduced to NO in the 
stomach [29–31]. The highest NO concentration is obtained from an acidic stomach pH after 
a NO
3
−‐rich meal (Figure 1) [29].
The rapid postprandial increase in gastric NO is directly proportional to many actions, such 
as mucus production in the gastrointestinal tract, increased vascular tone, antimicrobial 
effect, and immunomodulation. It has also been shown that this increased NO is related to 
many physiological mechanisms, such as the prevention of ischemia‐reperfusion injury and 
increased cerebral blood flow [21, 29].
How endogenous NO
3
− and NO
2
− can be synthesized in the body if NO
3
− and NO
2
− are not 
taken into the body with nutrients? The inorganic NO
3
− and NO
2
−, which cannot be taken up 
with nutrients in starving mammals, are mainly derived from NOSs. These enzymes form 
NO by using l‐arginine and oxygen, and then this NO is rapidly degraded to NO
3
− and NO
2
−. 
Endogenous NO
3
− and NO
2
− are synthesized in this way [30]. Endogenous NO can also be 
produced by NOSs using NO
3
− and NO
2
− in our daily nutrients [30, 32].
NO is a highly diffusible free radical that participates in various in vivo signal pathways and is 
involved in critical physiological events, such as regulation of vascular tone and immune response 
[31]. NO also exhibits antimicrobial activity [33] other than its regulatory role in vascular tone. 
Numerous intracellular pathogenic parasites [34] and bacteria [35] are susceptible to NO.
NO
2
− in saliva is converted non‐enzymatically into NO and some other nitrogen oxide species 
when it enters into the stomach with low pH [30]. Increasing number of studies on cardio‐
vascular, inflammatory, and gastrointestinal diseases reported that the NO‐related effects of 
dietary NO
3
− and NO
2
− are protective and preventive. Recent data suggest that these anions 
are beneficial to gastrointestinal cancer [36] and cardiovascular diseases rather than having 
harmful effects. Dietary NO
3
− and salivary NO
2
− have been shown to protect gastric mucus 
from experimentally induced gastric damage by increasing gastric mucus thickness and 
mucosal blood flow [30].
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NO plays an important role for the intestine. It is produced from arginine by eNOS and 
iNOS in a reaction catalyzed in the intestine. eNOS is structurally expressed in low levels 
in intestinal microcapillaries and is responsible for the initial levels of NO. Low NO lev‐
els regulate vascular tone and mucosal blood flow in cyclic guanosine monophosphate 
and neuron‐dependent manner and are also crucial for mucosal homeostasis. Additionally, 
NO can protect from oxidative stress by diminishing oxygen radicals. eNOS‐derived NO 
facilitates leucocyte uptake by supporting endothelial adhesion of leukocytes. iNOS is 
upregulated during inflammation and increases NO synthesis. NO also allows dilatation 
of capillary vessels. Excess NO secreted during inflammation has harmful effects on the 
intestinal barrier [37, 38].
NO reacts with the superoxide ion to form a reactive oxygen and nitrogen type, peroxynitrite, 
which can be harmful for epithelial cells. It can induce enterocyte cell apoptosis and inhibit 
proliferation. iNOS is expressed in intestinal smooth muscle cells, endothelial and epithelial 
cells [38]. During inflammatory conditions in the intestine, such as necrotizing enterocolitis 
[39], ulcer [29], and colon cancer [40], expression of iNOS mRNA increases.
Numerous studies have shown that NO
3
− and NO
2
− obtained from pharmacologic supple‐
ments or diet have obvious effects on gastrointestinal function [29, 39, 40]. However, it is still 
unclear whether endogenous NO
3
− and NO
2
− derived from NOSs in the endothelium and 
elsewhere affect gastric function. This situation has been tried to be illuminated in germ‐free 
and starved animals [30, 41].
The gastric NO levels are very low in germ‐free animals lacking microflora even after dietary 
NO
3
− load. A significant amount of NO
2
− is produced in the saliva even in the case of fasting, 
indicating NO
3
− production due to endogenous NOS production [30]. Petersson et al. [30] 
reported that three doses of NO
2
− given to germ‐free rats not only increased stomach mucus 
thickness by more than fourfold but also unexpectedly had an effect in the non‐NO
2
− group. 
This suggests that endogenous NO
3
− from NOSs also plays a role in the regulation of gastric 
physiology. In a similar study in humans, individuals were given a low NO
3
− diet with an 
antibacterial mouthwash containing chlorhexidine to lower the reduction of oral NO
3
−, and it 
was determined that the levels of circulating NO
2
− lowered, and this then increased the blood 
pressure [42]. These studies show that NO
3
− and NO
2
− have a NO
3
−‐NO
2
−‐NO pathway that 
starts from the mouth and ends in the mouth through digestive and circulatory system. It is 
possible that NO
3
− and NO
2
− in the circulation and saliva may originate from the endogenous 
NOS pathway.
In addition to NO
3
−, NO
2
−, NO, sodium nitrite (NaNO
2
) is an inorganic compound taken by 
endogenous sources. NaNO
2
 may have some beneficial and undesirable effects. NaNO
2
 is a 
preservative used in processed meats, such as salami and bacon. NaNO
2
 is synthesized by 
several chemical reactions, including the reduction of sodium nitrate. NaNO
2
 is used as an 
additive in foods. There are some suspects about the safety of use in foods, but it is still being 
used, and, on the contrary, there is information that NaNO
2
 may actually be healthy [43]. 
There are studies on the effects of NaNO
2
 on human health from 1945 [44] to present date [45].
NO
3
− salts are used as a cheap nitrogen source in fertilizers. Therefore, with the widespread 
use of nitrogenous fertilizers in agriculture and inappropriate disposal of nitrogenous wastes, 
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humans are exposed to high NO
3
−/NO
2
− levels at an alarming rate, especially through contam‐
inated food and water [46]. Infants and individuals with deficiency of glucose‐6‐phosphate 
dehydrogenase are particularly sensitive to high levels of NO
3
−/NO
2
− [45]. The digestive sys‐
tem of newborn babies convert NO
3
− to NO
2
−, and NO
2
− reacts with hemoglobin and prevents 
oxygen transport to the tissues. As a result, “methemoglobinemia” known as “blue baby syn‐
drome” occurs in infants [47].
Prolonged non‐lethal exposure to high levels of NO
3
−/NO
2
− may cause respiratory failure, 
growth failure, diabetes, neurological disorders, and cancer [48]. NaNO
2
 causes oxidative 
stress in human erythrocytes in vitro by increasing lipid and protein oxidation, osmotic fra‐
gility, and membrane damage [49].
Despite the fact that NaNO
2
 has not been reliable in the past and has the potential to cause 
many cancers, it has recently been reported that it can prevent myocardial ischemia‐reperfu‐
sion injury in diabetic rats by regulating eNOS and iNOS expression and inhibiting lipid 
peroxidation in the heart [50]. It also prevents hypertension and increases endothelium‐
dependent relaxation and total NO by regulating eNOS activity [51].
Serum malondialdehyde, NO, arginase, and glutathione S‐transferase activities were incre‐
ased, and glutathione and catalase activities were decreased in NaNO
2
‐treated rats [52]. In 
another study, decrease in GSH and catalase activity was reported in NaNO
2
‐intoxicated rats 
[53]. In their study investigating the histopathological, biochemical, and genotoxic effects of 
low dose NaNO
2
 administration for 8 months, Ozen et al. [54] reported that the liver and kid‐
ney NO levels were decreased in rats. The reduction in NO levels may be explained by the 
rapid and/or efficient removal of this molecule from these tissues, resulting in an increase in 
serum levels due to reduced NO by metabolic depletion. Therefore, the investigators reported 
that the increased serum NO level did not contradict with the decreasing NO level in the tis‐
sues [54]. In addition, these and other investigators indicated that chronic administration of 
NaNO
2
 increased iNOS activity in experimental animals [54, 55].
Peroxynitrite can interact with tyrosine residues to form nitrotyrosine. Ozen et al. [54] showed 
that the expression of iNOS and nitrotyrosine was increased in the liver and kidney tissues of 
NaNO
2
‐treated mice, and it caused tissue degeneration in both organs. Peroxynitrite can be 
decomposed to form NO
3
− and NO
2
− which can cause DNA damage, as well [56, 57].
The mechanisms of NaNO
2
 are still not fully understood; this suggests that further work 
needs to be performed in the future.
4. N‐nitroso compounds
4.1. The chemical structure and sources of N‐nitroso compounds
NO
2
− is the precursor of N‐nitroso compounds that have carcinogenic effect [58, 59]. NO
2
− is 
converted into nitrous acid in acidic environment, and nitrous acids react with secondary 
amines to form nitrosamine compounds (Figure 2) [60].
Nitric Oxide Synthase - Simple Enzyme-Complex Roles202
Nitrosamines are chemical compounds with general formulas as shown in (Figure 3).
Nitrosamines are used in the manufacture of some cosmetics, pesticides, and most rubber 
products [61, 62]. Nitrosamines are found in latex products, cereal, tea, many foods, ciga‐
rettes, and cigarette smoke [60]. They are also formed by the reduction of NO
3
−, which is 
abundant in nature, into NO
2
− by bacteria [27].
The most commonly used N‐nitroso compounds for the purpose of toxicity are N‐nitrosodi‐
methylamine, N‐nitrosodiethylamine, N‐nitrosopyrrolidine, and N‐nitrosopiperidine [63, 64].
Dimethylnitrosamine (also called N‐nitrosodimethylamine, DMN, DMNA, NDMA—C
2
H
6
N
2
O) 
is found in wheat flour, cheese, smoked meat, fish, and other food products (Figure 4) [65]. It 
can be formed by reaction of dimethylamine with NO
2
−. In addition, it can be formed by nitro‐
zation and decarboxylation of amino acids, such as glycine and alanine [66].
Diethylnitrosamine (also called N‐nitrosodiethylamine, DEN, DENA, NDEA—C
4
H
10
N
2
O) is 
found in chemicals used in agriculture and rubber industry, cigarette smoke, alcoholic bever‐
ages, and processed meat products (Figure 5) [67]. It can be formed by reaction of diethyl‐
amine with NO
2
−. Additionally, it can be formed by nitrozation and decarboxylation of amino 
acids, such as glycine alanine [66].
Figure 2. Formation of nitrosamine from NO
3
−.
Figure 3. Chemical formula for nitrosamine.
Figure 4. Chemical formula for dimethylnitrosamine.
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N‐nitrosopyrrolidine (also called NPYR—C
4
H
8
N
2
O) is found in cigarette smoke, meat and 
fish products (Figure 6) [68]. In meat products, this compound is formed by the nitrozation 
and decarboxylation of l‐proline [69].
N‐nitrosopiperidine (also called NPIP—C
5
H
10
N
2
O) formation follows these steps: decarbox‐
ylation of lysine results in cadaverine; cadaverine is converted into piperidine by heat and the 
reaction of the resulting piperidine with NO
2
− (Figure 7) [69, 70].
N‐nitrosamines can be found in food products and might cause serious health problems for 
humans.
4.2. N‐nitrosamines in meat and dairy products
N‐nitrosamines taken with food and found in the environment have been found to cause 
serious health risks above a certain level, even though they have both food processing and 
protection functions as additives.
Nitrosamines occur mostly in meat and dairy products [71]. Since meat, an important nutri‐
ent, is easily decomposed by different factors, it is necessary to protect it with various meth‐
ods and to increase its durability. For this purpose, some ingredients are added to meat and 
Figure 5. Chemical formula for diethylnitrosamine.
Figure 6. Chemical formula for N‐nitrosopyrrolidine.
Figure 7. Chemical formula for N‐nitrosopiperidine.
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meat products. Cured meat products, unlike fresh meat or salted meat with only table salt, 
have a pleasant smell, flavor, and a natural looking but a heat‐resistant color. Today, this 
process is applied to most of the meat products consumed [72, 73]. It has been reported that 
the degradation products of NO
3
− and NO
2
− result in the formation of carcinogenic nitrosa‐
mines by combining with amino acids, such as putrescine, thiamine, piperidine, pyrrolidine, 
histamine, cadaverine, trimethylamine, β‐phenylethylamine, n‐propylamine, and isopropyl‐
amine [74–77].
The most important sources of nitrosamines in dairy products, such as cheese and butter, are 
NO
3
−, NO
2
−, and amine compounds [78]. The metabolic activities of some microorganisms in 
milk and dairy products result in the formation of histamine and tyramines, and nitrosamines 
are formed by the reaction of the secondary amines, which are the degradation products of 
these biogenic amines in various ways, with NO
2
− [65, 69].
The first formation of these nitrosamines in meat and dairy products is seen in the oral cavity 
[79]. The salivary secretion contains abundant NO
3
− and this NO
3
− is reduced to NO
2
− by nitrate 
reductase enzyme [72]. This NO
2
− causes the formation of nitrosamines [80]. These compounds 
can be taken into the stomach in various ways, such as ingestion or smoking, or can also be 
formed by the reaction of NO
2
− and amines in acidic conditions [81]. Some bacteria in the 
stomach and intestines increase the formation of nitrosamines by facilitating the conversion 
of NO
3
− into NO
2
−. NO
2
− transforms into nitrous acid in the acidic environment of the stom‐
ach, and nitrous acid reacts with amines in the environment to form nitrosamines [60, 82]. 
Nitrosamines are usually excreted through urine [83, 84].
5. The roles of NOS isoforms and N‐nitrosamine compounds in liver 
toxicity or carcinogenesis
NO
3
− can easily be formed in mammalian systems through bacterial and mammalian enzymes. 
The resulting NO
3
− can then react with amines, amides, and amino acids to form N‐nitroso 
compounds. While NO
3
− has relatively low toxicity, NO
2
− and N‐nitroso compounds have 
higher toxicity in mammals. For this reason, there are many studies investigating the toxic‐
ity of these two molecules, as well as studies investigating ways to decrease the detrimental 
effects of these two molecules [20]. It has been suggested in long‐term experimental animal 
studies that nitrosamines cause cancer in many tissues, but the role of nitrosamines in the 
formation of cancers is still being investigated.
5.1. NOS isoforms in carcinogenesis
Various studies have indicated that three NOS isoforms both trigger and prevent cancer etiol‐
ogy. Nitric oxide synthase activity has been detected in a variety of tumor cells, and it has been 
shown to be closely related to tumor grade, proliferation rate, and cancer development. High 
NOS expression can be cytotoxic for cancer cells. On the other hand, low NOS expression may 
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have an adverse effect and may increase tumor development [85, 86]. For this reason, NOS 
can be both genotoxic and angiogenic. High NO production leads to angiogenesis by increas‐
ing the VEGF gene, especially in p53 mutant cells. In addition, NO can alter the expressions 
of DNA repair proteins, such as poly (ADP‐ribose) polymerase and DNA‐protein kinase in 
tumor cells. NO may exhibit carcinogenic effect by the production of different NO metabo‐
lites. For example, NO may rapidly react with intracellular environment to form N‐nitroso 
compounds. These metabolites, for example, can cause genotoxic effects by creating DNA 
damage [86]. In some other studies, N‐nitroso compounds have been reported to alter the 
activity of creatine kinase, lactate dehydrogenase [87], pyruvate kinase [88], and Na/K‐ATPase 
[89] enzymes.
5.2. N‐nitrosamine compounds in liver toxicity and cancer
Certain levels of nitrosamines taken in the body with any food ingredient are less likely to 
cause cancer in the human body alone. However, different types of nitrosamines, which are 
continuously taken from different sources, such as air and cigarettes, increase the risk of 
developing cancer [65, 90]. Although NO
3
− and NO
2
− create a toxicological problem, the main 
problem is that they turn into nitrosamines, which are carcinogenic. Nitrosamines are known 
to exhibit carcinogenic effect through binding to proteins and nucleic acids [91]. Nitrosamines 
also have mutagenic and teratogenic effects [61]. Because many organ‐specific nitrosamines 
are metabolized in the same way in human and animal tissues, humans are very sensitive to 
the carcinogenic properties of nitrosamines [67]. N‐nitroso compounds are potent alkylat‐
ing agents that can form endogenously and can cause cancer in surrounding animals [64]. 
Bacterial decarboxylation of amino acids in NO
3
− taken with nutrients results in amines and 
amides [58]. There is a relationship between the formation of N‐nitroso compounds by bacte‐
rial catalysis and increased risk for liver, stomach, esophagus, nasopharynx, chronic urinary 
tract infections, and bladder squamous cell carcinoma [77, 92].
Metabolic activations of the nitrosamines occur primarily in the liver, and this transfor‐
mation can occur in all cells. Dimethylnitrosamine is a potent carcinogen that can induce 
malignant tumors in various animal species in various tissues, including the liver, lungs, 
and stomach [79]. Various studies on different species of mice have shown that adenomas 
and adenocarcinomas in the lungs and hepatocarcinoma in the liver are formed by dimeth‐
ylnitrosamine. The target organs of dimethylnitrosamine are the liver, lungs, and kidneys 
[65, 79].
It is suggested that diethylnitrosamine metabolism is catalyzed by the enzymes of the multi‐
functional cytochrome P‐450 monooxygenase system and toxic effects are initiated by its meta‐
bolic activation, and that the resulting reactive intermediate products have little affinity for the 
catalytic domains of the binding enzymes, so that instead of being excreted with urine, they 
stimulate the onset of mutation, cancer, and necrosis by forming covalent bonds with impor‐
tant cellular components [93, 94]. Low concentrations of diethylnitrosamine cause mutations 
and cancer which was shown by the Ames assay [94]. Many studies suggest that the harmful 
effects of diethylnitrosamine may be reduced by various antioxidant molecules. The adminis‐
tration of molecules such as α‐lipoic acid [95], omega‐3 [96], blueberry [97], and beta‐carotene 
[98] were stated to reduce the carcinogenic effect of nitrosamines in experimental animals.
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N‐nitrosopiperidine and N‐nitrosopyrrolidine are structurally cyclic nitrosamines with dif‐
ferent carcinogenic activities. Comparative carcinogenicity studies of these two nitrosamines 
in rats revealed that N‐nitrosopiperidine caused esophagus, liver, and stomach tumors, and 
N‐nitrosopyrrolidine caused tumors mainly in the liver [63].
6. Conclusion
NO‐mediated responses are cell specific, and they depend on the existence of different NOS 
isoforms at different concentrations, and their regulations at pre‐ and post‐transcriptional 
levels are quite complex. The latest developments on strategies for treating or preventing 
pathological events in association with the stimulation or inhibition of excessive production 
of NO and N‐nitroso compounds present a crucial importance in medicine.
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